HNF4A and GATA6 Loss Reveals Therapeutically Actionable Subtypes in Pancreatic Cancer

Glasgow Precision Oncology Laboratory, Holly Brunton, Giuseppina Caligiuri, Richard Cunningham, Rosie Upstill-Goddard, Ulla-Maja Bailey, Ian M Garner, Craig Nourse, Stephan Dreyer, Marc Jones, Kim Moran-Jones, Derek W Wright, Viola Paulus-Hock, Colin Nixon, Gemma Thomson, Nigel B Jamieson, Grant A McGregor, Lisa Evers, Colin J McKay, Aditi GulatiRachel Brough, Ilirjana Bajrami, Stephen J Pettitt, Michele L Dziubinski, Simon T Barry, Robert Grützmann, Robert Brown, Edward Curry, Marina Pajic, Elizabeth A Musgrove, Gloria M Petersen, Emma Shanks, Alan Ashworth, Howard C Crawford, Diane M Simeone, Fieke E M Froeling, Christopher J Lord, Debabrata Mukhopadhyay, Christian Pilarsky, Sean E Grimmond, Jennifer P Morton, Owen J Sansom, David K Chang, Peter J Bailey, Andrew V Biankin

Research output: Contribution to journalArticlepeer-review

81 Citations (Scopus)
98 Downloads (Pure)

Fingerprint

Dive into the research topics of 'HNF4A and GATA6 Loss Reveals Therapeutically Actionable Subtypes in Pancreatic Cancer'. Together they form a unique fingerprint.

Medicine & Life Sciences

Chemistry